Back to BCAX
Vestal Point Capital, LP → BCAX
Vestal Point Capital, LP BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
4
Latest value
$102.8M
Q3 2026
Peak value
$155.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $60.2M |
| Q1 2026 | $107.9M |
| Q2 2026 | $155.9M |
| Q3 2026 | $102.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $102.8M | 5.53M | — | — |
| Q2 2026 | $155.9M | 5.25M | — | — |
| Q1 2026 | $107.9M | 5.42M | — | — |
| Q4 2025 | $60.2M | 3.58M | — | — |